Avantor (AVTR) Depreciation & Amortization (CF) (2018 - 2026)
Avantor (AVTR) recorded quarterly Depreciation & Amortization (CF) of $105.0 million in Q1 2026, up 1.65% quarter-over-quarter from $103.3 million in Q4 2025, and up 5.32% on a YoY basis from $99.7 million in Q1 2025.
Avantor (AVTR) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Avantor's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $105.0 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 5.32% year-over-year to $105.0 million; the TTM figure through Mar 2026 stood at $415.5 million (up 2.44% YoY), while the FY2025 annual figure was $410.2 million, up 1.16% from the prior year.
- Depreciation & Amortization (CF) was $105.0 million for Q1 2026 at Avantor, up from $103.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $114.5 million in Q1 2022 to a low of $89.7 million in Q2 2022.
- Historically, Depreciation & Amortization (CF) has averaged $101.7 million across 5 years, with a median of $101.1 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) rose 28.65% in 2022, then retreated 11.7% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $100.7 million in 2022, then fell by 0.1% to $100.6 million in 2023, then advanced by 0.3% to $100.9 million in 2024, then rose by 2.38% to $103.3 million in 2025, then grew by 1.65% to $105.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $105.0 million (Q1 2026), $103.3 million (Q4 2025), and $104.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 105.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.00 Mn |
| Mar 31, 2026 | 105.00 Mn |
| Dec 31, 2025 | 103.30 Mn |
| Dec 31, 2025 | 103.30 Mn |
| Sep 30, 2025 | 104.50 Mn |
| Sep 30, 2025 | 104.50 Mn |
| Jun 30, 2025 | 102.70 Mn |
| Jun 30, 2025 | 102.70 Mn |
| Mar 31, 2025 | 99.70 Mn |
| Mar 31, 2025 | 99.70 Mn |
| Dec 31, 2024 | 100.90 Mn |
| Dec 31, 2024 | 100.90 Mn |
| Sep 30, 2024 | 102.40 Mn |
| Sep 30, 2024 | 102.40 Mn |
| Jun 30, 2024 | 102.60 Mn |
| Jun 30, 2024 | 102.60 Mn |
| Mar 31, 2024 | 99.60 Mn |
| Mar 31, 2024 | 99.60 Mn |
| Dec 31, 2023 | 100.60 Mn |
| Dec 31, 2023 | 100.60 Mn |